BTIG Upgrades 1Life Healthcare to Buy, Announces $15 Price Target
BTIG analyst David Larsen upgrades 1Life Healthcare (NASDAQ:ONEM) from Neutral to Buy and announces $15 price target.
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers
Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Stifel Initiates Coverage On 1Life Healthcare with Buy Rating, Announces Price Target of $12
Stifel initiates coverage on 1Life Healthcare (NASDAQ:ONEM) with a Buy rating and announces Price Target of $12.
110 Biggest Movers From Friday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
SVB Leerink Maintains Market Perform on 1Life Healthcare, Lowers Price Target to $9
SVB Leerink analyst Whit Mayo maintains 1Life Healthcare (NASDAQ:ONEM) with a Market Perform and lowers the price target from $10 to $9.
Citigroup Maintains Buy on 1Life Healthcare, Lowers Price Target to $14
Citigroup analyst Daniel Grosslight maintains 1Life Healthcare (NASDAQ:ONEM) with a Buy and lowers the price target from $17 to $14.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Analyst Ratings For 1Life Healthcare
1Life Healthcare (NASDAQ:ONEM) has observed the following analyst ratings within the last quarter: